Unknown

Dataset Information

0

High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease.

ABSTRACT:

SUBMITTER: Li Y 

PROVIDER: S-EPMC8479016 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease.

Li Yan Y   Zhang Jinyong J   Duan Zilei Z   Wang Ning N   Sun Xiangcheng X   Zhang Yanjing Y   Fu Li L   Liu Kaiyun K   Yang Yongjun Y   Pan Shulei S   Shi Yun Y   Zeng Hao H   Guo Gang G   Lai Ren R   Zou Quanming Q  

Signal transduction and targeted therapy 20210929 1

Similar Datasets

Unknown Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2.
| S-EPMC7444494 | biostudies-literature
Unknown Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs.
| S-EPMC7659809 | biostudies-literature
Unknown Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach.
| S-EPMC7682381 | biostudies-literature
Unknown A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme☆
| S-EPMC8056978 | biostudies-literature
Unknown High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors.
| S-EPMC9871955 | biostudies-literature
Unknown Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease.
| S-EPMC7521772 | biostudies-literature
Unknown Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors.
| S-EPMC7316061 | biostudies-literature
Unknown Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease.
| S-EPMC11161032 | biostudies-literature
Unknown Improved SARS-CoV-2 main protease high-throughput screening assay using a 5-carboxyfluorescein substrate.
| S-EPMC8849842 | biostudies-literature
Unknown Drug development targeting SARS-CoV-2 main protease.
| S-EPMC9773221 | biostudies-literature